The Québec Government has partnered with the Medical Alley Association to deliver a customized U.S. go-to-market program for Québec companies in med-tech and digital health fields. The program, starting April 2021, will advance Québec’s and Medical Alley’s positions as global healthcare hubs.
Québecis a world-renowned innovation center with a fast-growing health-technology cluster. The region is determined to become one of the five major North American hubs in Life Sciences.
For the past ten years, Québec has spent more than any other Canadian province on research and development, in proportion to its GDP. It also receives more venture capital funding than any other Canadian province. This has accelerated the emergence of break-through companies like Repare Therapeutics, Imagia, CryoCath Technologies and a variety of innovative digital health companies.
“Québécois innovators will enhance U.S. healthcare quality, cost, and access. They represent first class innovation,” said Steffen Hovard, Interim President & CEO, Medical Alley Association.
Medical Alley, The Global Epicenter of Health Innovation and Care®, is the top health-technology cluster in the world. Home to global healthcare leaders like Mayo Clinic, UnitedHealth Group, and Medtronic, Medical Alley has the assets Québécois companies need to expand in the U.S. This includes developing U.S. strategies, identifying partners, and bringing lifesaving innovations to patients.
“Medical Alley is among the top healthcare hubs in the United States,” said Martine Hébert, Québec Government Delegate in Chicago. “By partnering with them, we give our Québec innovators access to experienced business leaders that have commercialized thousands of medical innovations.”
“Investissement Québec International oversees international trade within the Life Sciences sector and will work closely with Medical Alley and the Québec Government office in Chicago to build on this important collaboration and encourage trade between Québec , Minnesota and Medical Alley’s associates around the world.”, said Roch Paquette, Lead Council – Life Sciences, Investissement Québec International.
The U.S. healthcare market is the largest and most complex in the world. Because of this, startups from outside the country often struggle to break into the U. S. market. The new partnership between Medical Alley and Québecwill help innovators navigate into new markets.
“Partnering with the Québec Government builds on Medical Alley’s track record of welcoming global innovators and our experience with partnerships like the Medtech Bridge in Denmark, and BioMelbourne Network in Australia.” Frank Jaskulke, Vice President, Intelligence, Medical Alley Association
Medical Alley Association, Investissement Québec International and the QuébecDelegation in Chicago have designed a program to be delivered virtually and in-person if the environment permits that trains these businesses on the fundamentals of U.S. go-to-market strategy, connects with the potential partners and suppliers, and equips them to make go/no go decisions with confidence.